A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Dutta, Noton K ^a   Mehra, Smriti ^a   Kaushal, Deepak ^a,b  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; OXIDOREDUCTASE; SIGMA FACTOR; THIORIDAZINE; ANTIINFECTIVE AGENT;

AEROBIC METABOLISM; ARTICLE; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL SURVIVAL; CONTROLLED STUDY; ELECTRON MICROSCOPY; FATTY ACID METABOLISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPERON; OXIDATION REDUCTION POTENTIAL; REGULON; TRANSCRIPTOMICS; CELL WALL; DOSE RESPONSE; DRUG EFFECT; GENETICS; KINETICS; ULTRASTRUCTURE;

MYCOBACTERIUM TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; CELL WALL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, BACTERIAL; KINETICS; MYCOBACTERIUM TUBERCULOSIS; SIGMA FACTOR; THIORIDAZINE;

EID: 77956319845     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010069     Document Type: Article

References (58)

1. Raviglione MC (2007) The new stop TB strategy and the global plan to stop TB, 2006-2015. Bull World Health organ 85: 327.
2. Kristiansen JE (1991) Antimicrobial activity of non-antibiotics. ASM 57: 135-139.
3. Dutta NK, Mazumdar K, Dastidar SG, Park JH (2007) Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. Int J Antimicrob Agents 30: 336-340.
4. Dutta NK, Mazumdar K, DasGupta A, Dastidar SG (2009) Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice. J Med Microbiol 58:1667-1668.
5. Viveiros M, Amaral L (2001) Enhancement of antibiotic activity against polydrug resistant Mycobacterium tuberculosis by phenothiazines. Int J Antimicrob Agents 17: 225-228.
6. Kristiansen JE, Hendricks O, Delvin T, Butterworth TS, Aagaard L, et al. (2007) Reversal of resistance in microorganisms by help of non-antibiotics. J Antimicrob Chemother 59: 1271-1279.
7. Molnar J (2006) The reversal of drug resistance from bacteria to cancer cells. Curr Drug Targets 7: 789-791.
8. Klitgaard JK, Skov MN, Kallipolitis BH, Kolmos HJ (2008) Reversal of methicillin resistance in Staphylococcus aureus by thioridazine. J Antimicrob Chemother 62: 1215-1221.
9. Andrew MB, Paulsen IT, Piddock LJV (2008) RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine. Antimicrob Agents Chemother 52: 3604-3611.
10. Amaral L, Martins M, Viveiros M (2007) Enhanced killing of intracellular multidrug resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J Antimicrob Chemother 59: 1237-1246.
11. Amaral L, Martins M, Viveiros M, Molnar J, Kristiansen JE (2008) Promising therapy of XDR-TB/MDR-TB with thioridazine an inhibitor of bacterial efflux pumps. Current Drug Targets 9: 816-819.
12. Sacchettini JC, Rubin EJ, Freundlich JS (2008) Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat Rev Microbiol 6: 41-52.
13. Thioridazine (2008) Handbook of Anti-Tuberculosis Agents. Tubercul (Edinb) 88: 164-167.
14. Xie Z, Siddiqi N, Rubin EJ (2005) Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 49: 4778-4780.
15. Ordway D, Viveiros M, Leandro C, Bettencourt R, Almeida J, et al. (2003) Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 47: 917-922.
16. Bate AB, Kalin JH, Fooksman EM, Amorose E L, Price CM, et al. (2007) Synthesis and antitubercular activity of quaternized promazine and promethazine derivatives. Bioorg Med Chem Lett 17: 1346-1348.
17. Martins M, Dastidar SG, Fanning S, Kristiansen JE, Molnar J, et al. (2008) Potential role of non antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int J Antimicrob Agents 31: 198-208.
18. Martins M, Schelz Z, Martins A, Molnar J, Hajös G, et al. (2007) In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis. Int J Antimicrob Agents 29: 338-340.
19. Martins M, Viveiros M, Kristiansen JE, Molnar J, Amaral L (2007) The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis. In vivo 21:771-775.
20. Ratnakar P, Murthy P (1992) Antitubercular activity of trifluoperazine, a calmodulin antagonist. FEMS Microbiol Lett 97: 73-76.
21. Reddy MV, Nadadhur G, Gangadharam PR (1996) In-vitro and intracellular antimycobacterial activity of trifluoperazine. J Antimicrob Chemother 37: 196-197.
22. Boshoff HI, Myers TG, Copp BR, McNeil MR, Wilson MA, et al. (2004) The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J Biol Chem 279: 40174-40184.
23. Weinstein EA, Yano T, Li LS, Avarbock D, Avarbock A, et al. (2005) Inhibitors of type II NADH: menaquinone oxidoreductase represent a class of antitubercular drugs. Proc Natl Acad Sci USA 102: 4548-4553.
24. Yano T, Li LS, Weinstein E, The JS, Rubin H (2006) Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis type-II NADH menaquinone oxidoreductase (NDH-2). J Biol Chem 281:11456-11463.
25. Lonetto M, Gribskov M, Gross CA (1992) The σ70 family: sequence conservation and evolutionary relationships. J Bacteriol 174: 3843-3849.
26. Missiakas D, Raina S (1998) The extracytoplasmic function sigma factors: role and regulation. Mol Microbiol 28: 1059-1066.
27. Gomez JE, Chen JM, Bishai WR (1997) Sigma factors of Mycobacterium tuberculosis. Tuber Lung Dis 78: 175-183.
28. Kaushal D, Schroeder BG, Tyagi S, Yoshimatsu T, Scott C, et al. (2002) Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc Natl Acad Sci USA 99: 8330-8335.
29. Manganelli R, Voskuil MI, Schoolnik GK, Dubnau E, Gomez M, et al. (2002) Role of the extracytoplasmic-function sigma factor sigma (H) in Mycobacterium tuberculosis global gene expression. Mol Microbiol 45: 365-374.
30. Mehra S, Kaushal D (2009) Functional genomics reveals extended roles of the Mycobacterium tuberculosis stress response factor SigH, in response to oxidative stress. J Bacteriol 191: 3965-3980.
31. Ohno H, Zhu G, Mohan VP, Chu D, Kohno S, Jacobs WR, Jr., et al. (2003) The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis. Cell Microbiol 5: 637-648.
32. Graham JE, Clark-Curtiss JE (1999) Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc Natl Acad Sci USA 96: 11554-11559.
33. Rohde KH, Abramovitch RB, Russell DG (2007) Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe 2: 352-364.
34. Jensen-Cain DM, Quinn FD (2001) Differential expression of sigE by Mycobacterium tuberculosis during intracellular growth. Microb Pathog 30: 271-278.
35. Manganelli R, Voskuil MI, Schoolnik GK, Smith I (2001) The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages. Mol Microbiol 41: 423-437.
36. Pang X, Vu P, Byrd TF, Ghanny S, Soteropoulos P, Mukamolova GV, et al. (2007) Evidence for complex interactions of stress-associated regulons in an mprAB deletion mutant of Mycobacterium tuberculosis. Microbiology 153:1229-1242.
37. Fontán PA, Voskuil MI, Gomez M, Tan D, Pardini M, et al. (2009) The Mycobacterium tuberculosis sigma factor sigmaB is required for full response to cell envelope stress and hypoxia in vitro, but it is dispensable for in vivo growth. J Bacteriol 191: 5628-5633.
38. Provvedi R, Boldrin F, Falciani F, Palu G, Manganelli R (2009) Global transcriptional response to vancomycin in Mycobacterium tuberculosis. Microb 155: 1093-1102.
39. Singh A, Gupta R, Vishwakarma RA, Narayanan PR, Paramasivan CN, et al. (2005) Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs. J Bacteriol 187: 4173-4186.
40. Bishai WR, Dannenberg Jr. AM, Parrish N, Ruiz R, Chen P, et al. (1999) Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. Infect Immun 67: 4931-4934.
41. Lee JH, Karakousis PC, Bishai WR (2008) Roles of SigB and SigF in the Mycobacterium tuberculosis sigma factor network. J Bacteriol 190: 699-707.
42. San KY, Bennett GN, Berrios-Rivera SJ, Vadali RV, et al. (2002) Metabolic engineering through cofactor manipulation and its effects on metabolic flux redistribution in Escherichia coli. Metab Eng 4: 182-192.
43. Manca C, Tsenova L, Barry (III) CE, Bergtold A, Freeman S, et al. (1999) Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 162:6740-6746.
44. Chen P, Ruiz RE, Li Q, Silver RF, Bishai WR (2000) Construction and characterization of a Mycobacterium tuberculosis mutant lacking the alternate sigma factor gene, sigF. Infect Immun 68: 5575-5580.
45. Wilson M, DeRisi J, Kristensen HH, Imboden P, Rane S, et al. (1999) Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci USA 96: 12833-12838.
46. Joanna CB, McLaren A, Lennon MG, Kelly FM, Lukey PT, et al. (2003) Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis. Antimicrob Agents Chemother 47: 2903-2913.
47. Waddell SJ, Stabler RA, Laing K, Kremer L, Reynolds RC, et al. (2004) The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tubercul (Edinb) 84: 263-274.
48. Raghavan S, Manzanillo P, Chan K, Dovey C, Cox JS (2008) Secreted transcription factor controls Mycobacterium tuberculosis virulence. Nature 454: 717-721.
49. Predich M, Doukhan L, Nair G, Smith I (1995) Characterization of RNA polymerase and two sigma-factor genes from Mycobacterium smegmatis. Mol Microbiol 15: 355-366.
50. Sohaskey CD (2008) Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration. J Bacteriol 190: 2981-2986.
51. Li X-Z, Zhang L, Nikaido H (2004) Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother 48: 2415-2423.
52. Ando M, Yoshimatsu T, Ko C, Converse PJ, Bishai WR (2003) Deletion of Mycobacterium tuberculosis sigma factor E results in delayed time to death with bacterial persistence in the lungs of aerosol-infected mice. Infect Immun 71:7170-7172.
53. Manganelli R, Provvedi R, Rodrigue S, Beaucher J, Gaudreau L, Smith I (2004) Sigma factors and global gene regulation in Mycobacterium tuberculosis. J Bacteriol 186: 895-902.
54. Barik S, Sureka K, Mukherjee P, Basu J, Kundu M (2010) RseA, the SigE specific anti-sigma factor of Mycobacterium tuberculosis, is inactivated by phosphorylation-dependent ClpC1P2 proteolysis. Mol Microb 75: 592-606.
55. Manganelli R, Provvedi R (2010) An integrated regulatory network including two positive feedback loops to modulate the activity of sE in Mycobacteria. Mol Microb 75: 538-542.
56. Haydel SE, Clark-Curtiss JE (2006) The Mycobacterium tuberculosis TrcR response regulator represses transcription of the intracellularly expressed Rv1057 gene, encoding a seven-bladed {beta}-propeller. J Bacteriol 188: 150-159.
57. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, et al. (2003) Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J Exp Med 198: 693-704.
58. Deb C, Daniel J, Sirakova TD, Abomoelak B, Dubey VS, et al. (2006) A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis. J Biol Chem 281:3866-3875.